The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
DNA sequencing with chain-terminating inhibitors
Sanger, F., Nicklen, S., & Coulson, A. R. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.12.5463 · Cited by 68,572
The Rat Brain in Stereotaxic Coordinates
(1982) · Elsevier eBooks · doi:10.1016/c2009-0-63235-9 · Cited by 51,963
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
Chomczynski, P., & Sacchi, N. (1987) · Analytical Biochemistry · doi:10.1016/0003-2697(87)90021-2 · Cited by 46,426
The rat brain in stereotaxic coordinates
Palkovits, M. (1983) · Neuropeptides · doi:10.1016/0143-4179(83)90049-5 · Cited by 28,831
Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease
Chirgwin, J. M., Przybyla, A. E., MacDonald, R. J., & Rutter, W. J. (1979) · Biochemistry · doi:10.1021/bi00591a005 · Cited by 21,725
A new technique for the assay of infectivity of human adenovirus 5 DNA
Graham, F. L., & van der Eb, A. J. (1973) · Virology · doi:10.1016/0042-6822(73)90341-3 · Cited by 9,451
Aviv, H., & Leder, P. (1972) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.69.6.1408 · Cited by 6,751
Handbook of Chemical Neuroanatomy
Stern, C. D. (1986) · Neurochemistry International · doi:10.1016/0197-0186(86)90021-5 · Cited by 4,151
Multiple receptors for dopamine
Kebabian, J. W., & Calne, D. B. (1979) · Nature · doi:10.1038/277093a0 · Cited by 3,725
Compilation and analysis of sequences upstream from the translational start site in eukaryotic mRNAs
Kozak, M. (1984) · Nucleic Acids Research · doi:10.1093/nar/12.2.857 · Cited by 3,293
Cited by
Dopamine receptors: from structure to function
MISSALE, C., NASH, S. R., ROBINSON, S. W., JABER, M., & CARON, M. G. (1998) · Physiological Reviews · doi:10.1152/physrev.1998.78.1.189 · Cited by 3,633
The physiology, signaling, and pharmacology of dopamine receptors
Beaulieu, J.-M., & Gainetdinov, R. R. (2011) · Pharmacological Reviews · doi:10.1124/pr.110.002642 · Cited by 2,763
Dopamine in schizophrenia: a review and reconceptualization
(1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.11.1474 · Cited by 2,018
Van Tol, H. H. M., Bunzow, J. R., Guan, H.-C., Sunahara, R. K., Seeman, P., Niznik, H. B., & Civelli, O. (1991) · Nature · doi:10.1038/350610a0 · Cited by 2,014
Farde, L. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820070032005 · Cited by 1,419
Chronic mild stress-induced anhedonia: A realistic animal model of depression
Willner, P., Muscat, R., & Papp, M. (1992) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(05)80194-0 · Cited by 1,160
Schotte, A., Janssen, P. F. M., Gommeren, W., Luyten, W. H. M. L., Van Gompel, P., Lesage, A. S., De Loore, K., & Leysen, J. E. (1996) · Psychopharmacology · doi:10.1007/bf02245606 · Cited by 1,167
Cloning of the gene for a human dopamine D5 receptor with higher affinity for dopamine than D1
Sunahara, R. K., Guan, H.-C., O'Dowd, B. F., Seeman, P., Laurier, L. G., Ng, G., George, S. R., Torchia, J., Van Tol, H. H. M., & Niznik, H. B. (1991) · Nature · doi:10.1038/350614a0 · Cited by 1,165
Structure of the Human Dopamine D3 Receptor in Complex with a D2/D3 Selective Antagonist
Chien, E. Y. T., Liu, W., Zhao, Q., Katritch, V., Won Han, G., Hanson, M. A., Shi, L., Newman, A. H., Javitch, J. A., Cherezov, V., et al. (2010) · Science · doi:10.1126/science.1197410 · Cited by 1,128
The neostriatal mosaic: multiple levels of compartmental organization in the basal ganglia
Gerfen, C. R. (1992) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.15.030192.001441 · Cited by 1,004
Molecular biology of dopamine receptors
Sibley, D. R., & Monsma, F. J. (1992) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(92)90025-2 · Cited by 988
Aripiprazole, A Novel Atypical Antipsychotic Drug with a Unique and Robust Pharmacology
Shapiro, D. A., Renock, S., Arrington, E., Chiodo, L. A., Liu, L.-X., Sibley, D. R., Roth, B. L., & Mailman, R. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300203 · Cited by 968
Multiple dopamine D4 receptor variants in the human population
Tol, H. H. M. V., Wu, C. M., Guan, H.-C., Ohara, K., Bunzow, J. R., Civelli, O., Kennedy, J., Seeman, P., Niznik, H. B., & Jovanovic, V. (1992) · Nature · doi:10.1038/358149a0 · Cited by 955
Dopamine receptor pharmacology
Seeman, P., & Van Tol, H. H. M. (1994) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(94)90323-9 · Cited by 956
Bouthenet, M.-L., Souil, E., Martres, M.-P., Sokoloff, P., Giros, B., & Schwartz, J.-C. (1991) · Brain Research · doi:10.1016/0006-8993(91)91456-b · Cited by 868
Self-citationSequence Alignment of the G-Protein Coupled Receptor Superfamily
PROBST, W. C., SNYDER, L. A., SCHUSTER, D. I., BROSIUS, J., & SEALFON, S. C. (1992) · DNA and Cell Biology · doi:10.1089/dna.1992.11.1 · Cited by 845
Sun, F., Zeng, J., Jing, M., Zhou, J., Feng, J., Owen, S. F., Luo, Y., Li, F., Wang, H., Yamaguchi, T., et al. (2018) · Cell · doi:10.1016/j.cell.2018.06.042 · Cited by 837
The neuropsychological basis of addictive behaviour
Everitt, B. J., Dickinson, A., & Robbins, T. W. (2001) · Brain Research Reviews · doi:10.1016/s0165-0173(01)00088-1 · Cited by 808
Serotonin receptors : their key role in drugs to treat schizophrenia
Meltzer, H. Y., Li, Z., Kaneda, Y., & Ichikawa, J. (2003) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2003.09.010 · Cited by 775
Mukoyama, M., Nakajima, M., Horiuchi, M., Sasamura, H., Pratt, R. E., & Dzau, V. J. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)74498-6 · Cited by 768
Kambayashi, Y., Bardhan, S., Takahashi, K., Tsuzuki, S., Inui, H., Hamakubo, T., & Inagami, T. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)74499-8 · Cited by 714
Lévesque, D., Diaz, J., Pilon, C., Martres, M. P., Giros, B., Souil, E., Schott, D., Morgat, J. L., Schwartz, J. C., & Sokoloff, P. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.17.8155 · Cited by 674
Self-citationNoble, E. P. (1991) · Archives of General Psychiatry · doi:10.1001/archpsyc.1991.01810310066012 · Cited by 655
Mailleux, P., & Vanderhaeghen, J.-J. (1992) · Neuroscience · doi:10.1016/0306-4522(92)90409-u · Cited by 664
Dopamine D4 receptors elevated in schizophrenia
Seeman, P., Guan, H.-C., & Van Tol, H. H. M. (1993) · Nature · doi:10.1038/365441a0 · Cited by 628
Molecular Diversity of the Dopamine Receptors
Civelli, O., Bunzow, J. R., & Grandy, D. K. (1993) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.33.040193.001433 · Cited by 623
Ruat, M., Traiffort, E., Leurs, R., Tardivel-Lacombe, J., Diaz, J., Arrang, J. M., & Schwartz, J. C. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.18.8547 · Cited by 617
Self-citationBDNF controls dopamine D3 receptor expression and triggers behavioural sensitization
Guillin, O., Diaz, J., Carroll, P., Griffon, N., Schwartz, J.-C., & Sokoloff, P. (2001) · Nature · doi:10.1038/35075076 · Cited by 574
Self-citationDopamine receptors and brain function
Jaber, M., Robinson, S. W., Missale, C., & Caron, M. G. (1996) · Neuropharmacology · doi:10.1016/s0028-3908(96)00100-1 · Cited by 570
Martinez, D., Slifstein, M., Broft, A., Mawlawi, O., Hwang, D.-R., Huang, Y., Cooper, T., Kegeles, L., Zarahn, E., Abi-Dargham, A., et al. (2003) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/01.wcb.0000048520.34839.1a · Cited by 569
Dopaminergic and Ligand-Independent Activation of Steroid Hormone Receptors
Power, R. F., Mani, S. K., Codina, J., Conneely, O. M., & O'Malley, B. W. (1991) · Science · doi:10.1126/science.1749936 · Cited by 567
Selective inhibition of cocaine-seeking behaviour by a partial dopamine D3 receptor agonist
Pilla, M., Perachon, S., Sautel, F., Garrido, F., Mann, A., Wermuth, C. G., Schwartz, J.-C., Everitt, B. J., & Sokoloff, P. (1999) · Nature · doi:10.1038/22560 · Cited by 565
Self-citationPathological Gambling Caused by Drugs Used to Treat Parkinson Disease
Dodd, M. L., Klos, K. J., Bower, J. H., Geda, Y. E., Josephs, K. A., & Ahlskog, J. E. (2005) · Archives of Neurology · doi:10.1001/archneur.62.9.noc50009 · Cited by 563
The Concise Guide to PHARMACOLOGY 2013/14: G Protein‐Coupled Receptors
Alexander, S. P. H., Benson, H. E., Faccenda, E., Pawson, A. J., Sharman, J. L., Spedding, M., Peters, J. A., Harmar, A. J., & Collaborators, C. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12445 · Cited by 556
Regulation of affect by the lateral septum: implications for neuropsychiatry
Sheehan, T. P., Chambers, R. A., & Russell, D. S. (2004) · Brain Research Reviews · doi:10.1016/j.brainresrev.2004.04.009 · Cited by 514
Dopamine Signaling in reward-related behaviors
Baik, J.-H. (2013) · Frontiers in Neural Circuits · doi:10.3389/fncir.2013.00152 · Cited by 531
Nordström, A.-L., Farde, L., Wiesel, F.-A., Forslund, K., Pauli, S., Halldin, C., & Uppfeldt, G. (1993) · Biological Psychiatry · doi:10.1016/0006-3223(93)90288-o · Cited by 527
Mawlawi, O., Martinez, D., Slifstein, M., Broft, A., Chatterjee, R., Hwang, D.-R., Huang, Y., Simpson, N., Ngo, K., Van Heertum, R., et al. (2001) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200109000-00002 · Cited by 525
“Sokoloff et al. (1990) reported dopamine affinity of 474 nmol/L and 25 nmol/L for D2 and D3 receptors, respectively, an observation replicated by several laboratories (Levant, 1997).”
ResultA hypervariable segment in the human dopamine receptor D4 (DRD4) gene
Lichter, J. B., Barr, C. L., Kennedy, J. L., Van Tol, H. H. M., Kidd, K. K., & Livak, K. J. (1993) · Human Molecular Genetics · doi:10.1093/hmg/2.6.767 · Cited by 524
Metabotropic glutamate receptor mRNA expression in the basal ganglia of the rat
Testa, C., Standaert, D., Young, A., & Penney, J. (1994) · The Journal of Neuroscience · doi:10.1523/jneurosci.14-05-03005.1994 · Cited by 510
Pathophysiology of levodopa-induced dyskinesia: Potential for new therapies
Bezard, E., Brotchie, J. M., & Gross, C. E. (2001) · Nature Reviews Neuroscience · doi:10.1038/35086062 · Cited by 503
Sodium-Potassium-Adenosinetriphosphatase-Dependent Sodium Transport in the Kidney: Hormonal Control
Féraille, E., & Doucet, A. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.1.345 · Cited by 500
Xu, M., Moratalla, R., Gold, L. H., Hiroi, N., Koob, G. F., Graybiel, A. M., & Tonegawa, S. (1994) · Cell · doi:10.1016/0092-8674(94)90557-6 · Cited by 484
Dopamine receptors: Molecular biology, biochemistry and behavioural aspects
Jackson, D. M., & Westlind-Danielsson, A. (1994) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(94)90041-8 · Cited by 483
Pharmacology and behavioral pharmacology of the mesocortical dopamine system
Tzschentke, T. M. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(00)00033-2 · Cited by 481
Robertson, G. S., & Fibiger, H. C. (1992) · Neuroscience · doi:10.1016/0306-4522(92)90054-6 · Cited by 474
Phenotypical characterization of the rat striatal neurons expressing the D1 dopamine receptor gene.
Le Moine, C., Normand, E., & Bloch, B. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.10.4205 · Cited by 472
Cortical maldevelopment, anti-psychotic drugs, and schizophrenia: a search for common ground
Weinberger, D. R., & Lipska, B. K. (1995) · Schizophrenia Research · doi:10.1016/0920-9964(95)00013-c · Cited by 470
A targeted mutation of the D3 dopamine receptor gene is associated with hyperactivity in mice.
Accili, D., Fishburn, C. S., Drago, J., Steiner, H., Lachowicz, J. E., Park, B. H., Gauda, E. B., Lee, E. J., Cool, M. H., Sibley, D. R., et al. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.5.1945 · Cited by 468
Sesack, Sr., Aoki, C., & Pickel, V. (1994) · The Journal of Neuroscience · doi:10.1523/jneurosci.14-01-00088.1994 · Cited by 461
Modulation of Cocaine Self-Administration in the Rat Through D-3 Dopamine Receptors
Caine, S. B., & Koob, G. F. (1993) · Science · doi:10.1126/science.8099761 · Cited by 454
Imaging dopamine receptors in humans with [11C]-(+)-PHNO: Dissection of D3 signal and anatomy
Tziortzi, A. C., Searle, G. E., Tzimopoulou, S., Salinas, C., Beaver, J. D., Jenkinson, M., Laruelle, M., Rabiner, E. A., & Gunn, R. N. (2011) · NeuroImage · doi:10.1016/j.neuroimage.2010.06.044 · Cited by 452
Verma, A., & Moghaddam, B. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-01-00373.1996 · Cited by 449
Alcohol dependence is associated with blunted dopamine transmission in the ventral striatum
Martinez, D., Gil, R., Slifstein, M., Hwang, D.-R., Huang, Y., Perez, A., Kegeles, L., Talbot, P., Evans, S., Krystal, J., et al. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.04.044 · Cited by 445
Gurevich, E. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(98)00066-9 · Cited by 431
Dopamine receptor subtypes colocalize in rat striatonigral neurons.
Surmeier, D. J., Eberwine, J., Wilson, C. J., Cao, Y., Stefani, A., & Kitai, S. T. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.21.10178 · Cited by 430
Melis, M. R., & Argiolas, A. (1995) · Neuroscience & Biobehavioral Reviews · doi:10.1016/0149-7634(94)00020-2 · Cited by 429
The dopamine D4 receptor: one decade of research
Oak, J. N., Oldenhof, J., & Van Tol, H. H. M. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00562-8 · Cited by 419
The Mechanism of Action of Novel Antipsychotic Drugs
Meltzer, H. Y. (1991) · Schizophrenia Bulletin · doi:10.1093/schbul/17.2.263 · Cited by 411
Lawler, C. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(98)00099-2 · Cited by 408
Sokoloff, P., Andrieux, M., Besançon, R., Pilon, C., Martres, M.-P., Giros, B., & Schwartz, J.-C. (1992) · European Journal of Pharmacology: Molecular Pharmacology · doi:10.1016/0922-4106(92)90107-7 · Cited by 400
Self-citationDopamine functions in appetitive and defensive behaviours
Blackburn, J. R., Pfaus, J. G., & Phillips, A. G. (1992) · Progress in Neurobiology · doi:10.1016/0301-0082(92)90018-a · Cited by 394
Genetics of dopamine receptors and drug addiction: a comprehensive review
Foll, B. L., Gallo, A., Strat, Y. L., Lu, L., & Gorwood, P. (2009) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e3283242f05 · Cited by 393
The D3 Dopamine Receptor: Neurobiology and Potential Clinical Relevance
Levant, B. (1997) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01327-9 · Cited by 385
Striatal dopamine neurotransmission: Regulation of release and uptake
Sulzer, D., Cragg, S. J., & Rice, M. E. (2016) · Basal Ganglia · doi:10.1016/j.baga.2016.02.001 · Cited by 382
Schoemaker, H., Claustre, Y., Fage, D., Rouquier, L., Chergui, K., Curet, O., Oblin, A., Gonon, F., Carter, C., Benavides, J., et al. (1997) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36395-5 · Cited by 371
Kiss, B., Horváth, A., Némethy, Z., Schmidt, É., Laszlovszky, I., Bugovics, G., Fazekas, K., Hornok, K., Orosz, S., Gyertyán, I., et al. (2010) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.160432 · Cited by 367
Neurobiology of Dopamine in Schizophrenia
Guillin, O., Abi‐Dargham, A., & Laruelle, M. (2007) · International Review of Neurobiology · doi:10.1016/s0074-7742(06)78001-1 · Cited by 365
“1990), as well as three newer DA receptors, termed D3, D4 and D5 receptors (Sokoloff et al. 1990; Sunahara et al. 1991; Tiberi et al. 1991; Van Tol et al. 1991).”
BackgroundChapter 19 The determinants of stress-induced activation of the prefrontal cortical dopamine system
(1991) · Progress in Brain Research · doi:10.1016/s0079-6123(08)62691-6 · Cited by 364
Bodi, N., Keri, S., Nagy, H., Moustafa, A., Myers, C. E., Daw, N., Dibo, G., Takats, A., Bereczki, D., & Gluck, M. A. (2009) · Brain · doi:10.1093/brain/awp094 · Cited by 363
Cyclopropane Derivatives and their Diverse Biological Activities
Salaün, J. (2000) · Topics in Current Chemistry · doi:10.1007/3-540-48255-5_1 · Cited by 361
Tiberi, M., Jarvie, K. R., Silvia, C., Falardeau, P., Gingrich, J. A., Godinot, N., Bertrand, L., Yang-Feng, T. L., Fremeau, R. T., & Caron, M. G. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.17.7491 · Cited by 359
Fremeau, R. T., Duncan, G. E., Fornaretto, M. G., Dearry, A., Gingrich, J. A., Breese, G. R., & Caron, M. G. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.9.3772 · Cited by 354
Phenotypical characterization of neurons expressing the dopamine D3 receptor in the rat brain
Diaz, J., Lévesque, D., Lammers, C. H., Griffon, N., Martres, M.-P., Schwartz, J.-C., & Sokoloff, P. (1995) · Neuroscience · doi:10.1016/0306-4522(94)00527-c · Cited by 352
Self-citationAge-related dopamine D2/D3 receptor loss in extrastriatal regions of the human brain
Kaasinen, V (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00149-4 · Cited by 352
Role of the dopaminergic system in depression
Kapur, S., & John Mann, J. (1992) · Biological Psychiatry · doi:10.1016/0006-3223(92)90137-o · Cited by 348
Induction of dopamine D 3 receptor expression as a mechanism of behavioral sensitization to levodopa
Bordet, R., Ridray, S., Carboni, S., Diaz, J., Sokoloff, P., & Schwartz, J.-C. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.7.3363 · Cited by 345
Self-citationJones, G. H., Hernandez, T. D., Kendall, D. A., Marsden, C. A., & Robbins, T. W. (1992) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(92)90635-s · Cited by 341
Dopamine, a neurotransmitter, influences the immune system
Basu, S., & Dasgupta, P. S. (2000) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(99)00176-9 · Cited by 335
Leysen, J. E., Janssen, P. M. F., Schotte, A., Luyten, W. H. M. L., & Megens, A. A. H. P. (1993) · Psychopharmacology · doi:10.1007/bf02245006 · Cited by 334
Nguyen, T. V., Kosofsky, B. E., Birnbaum, R., Cohen, B. M., & Hyman, S. E. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.10.4270 · Cited by 331
Dopamine D3Receptors Expressed by All Mesencephalic Dopamine Neurons
Diaz, J., Pilon, C., Le Foll, B., Gros, C., Triller, A., Schwartz, J.-C., & Sokoloff, P. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-23-08677.2000 · Cited by 326
Self-citationThe Pharmacology of l-DOPA-Induced Dyskinesia in Parkinson’s Disease
Huot, P., Johnston, T. H., Koprich, J. B., Fox, S. H., & Brotchie, J. M. (2013) · Pharmacological Reviews · doi:10.1124/pr.111.005678 · Cited by 324
The role of central dopamine D3 receptors in drug addiction: a review of pharmacological evidence
Heidbreder, C. A., Gardner, E. L., Xi, Z.-X., Thanos, P. K., Mugnaini, M., Hagan, J. J., & Ashby, C. R. (2005) · Brain Research Reviews · doi:10.1016/j.brainresrev.2004.12.033 · Cited by 322
The Role of the Striatopallidal and Extended Amygdala Systems in Drug Addiction
KOOB, G. F. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb09282.x · Cited by 321
Mechanisms of action of atypical antipsychotic drugs: a critical analysis
Kinon, B. J., & Lieberman, J. A. (1996) · Psychopharmacology · doi:10.1007/bf02245602 · Cited by 317
Xu, M., Koeltzow, T. E., Santiago, G. T., Moratalla, R., Cooper, D. C., Hu, X.-T., White, N. M., Graybiel, A. M., White, F. J., & Tonegawa, S. (1997) · Neuron · doi:10.1016/s0896-6273(00)80965-4 · Cited by 315
Third Generation Antipsychotic Drugs: Partial Agonism or Receptor Functional Selectivity?
Mailman, R., & Murthy, V. (2010) · Current Pharmaceutical Design · doi:10.2174/138161210790361461 · Cited by 311
Martinez, D., Broft, A., Foltin, R. W., Slifstein, M., Hwang, D.-R., Huang, Y., Perez, A., Frankel, W. G., Cooper, T., Kleber, H. D., et al. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300420 · Cited by 306
Adaptive Increase in D3Dopamine Receptors in the Brain Reward Circuits of Human Cocaine Fatalities
Staley, J. K., & Mash, D. C. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-19-06100.1996 · Cited by 308
What Keeps Us Awake: the Neuropharmacology of Stimulants and Wakefulness Promoting Medications
Boutrel, B., & Koob, G. F. (2004) · Sleep · doi:10.1093/sleep/27.6.1181 · Cited by 307
Kim, K.-M., Valenzano, K. J., Robinson, S. R., Yao, W. D., Barak, L. S., & Caron, M. G. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106728200 · Cited by 304
Dopamine, the prefrontal cortex and schizophrenia
Knable, M. B., & Weinberger, D. R. (1997) · Journal of Psychopharmacology · doi:10.1177/026988119701100205 · Cited by 303
Targeting the dopamine D2receptor in schizophrenia
Seeman, P. (2006) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.10.4.515 · Cited by 302
Paul, M., Graybiel, A., David, J., & Robertson, H. (1992) · The Journal of Neuroscience · doi:10.1523/jneurosci.12-10-03729.1992 · Cited by 299
de la Mora, M. P., Gallegos-Cari, A., Arizmendi-García, Y., Marcellino, D., & Fuxe, K. (2010) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2009.10.010 · Cited by 296
Steketee, J. (2003) · Brain Research Reviews · doi:10.1016/s0165-0173(02)00233-3 · Cited by 293
Tonini, M., Cipollina, L., Poluzzi, E., Crema, F., Corazza, G. R., & De Ponti, F. (2004) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2004.01867.x · Cited by 291
Reversal learning in Parkinson's disease depends on medication status and outcome valence
Cools, R., Altamirano, L., & D’Esposito, M. (2006) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2006.03.030 · Cited by 289
Klos, K. J., Bower, J. H., Josephs, K. A., Matsumoto, J. Y., & Ahlskog, J. E. (2005) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2005.06.005 · Cited by 283
Metadata
- Authors
- Sokoloff, P., Giros, B., Martres, M.-P., Bouthenet, M.-L., & Schwartz, J.-C.
- Venue
- Nature
- Published
- 1990-09
- Volume
- 347
- Issue
- 6289
- Pages
- 146-151
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1966092598
- Cited by
- 2,609
- References
- 44
- FWCI
- 67.60
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.